1. Home
  2. SION vs LEGH Comparison

SION vs LEGH Comparison

Compare SION & LEGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SION
  • LEGH
  • Stock Information
  • Founded
  • SION 2019
  • LEGH 2005
  • Country
  • SION United States
  • LEGH United States
  • Employees
  • SION N/A
  • LEGH N/A
  • Industry
  • SION
  • LEGH Homebuilding
  • Sector
  • SION
  • LEGH Consumer Discretionary
  • Exchange
  • SION NYSE
  • LEGH Nasdaq
  • Market Cap
  • SION 564.4M
  • LEGH 588.8M
  • IPO Year
  • SION 2025
  • LEGH 2018
  • Fundamental
  • Price
  • SION $21.19
  • LEGH $23.97
  • Analyst Decision
  • SION Strong Buy
  • LEGH Strong Buy
  • Analyst Count
  • SION 1
  • LEGH 2
  • Target Price
  • SION $32.00
  • LEGH $29.00
  • AVG Volume (30 Days)
  • SION 267.3K
  • LEGH 104.8K
  • Earning Date
  • SION 08-25-2025
  • LEGH 08-07-2025
  • Dividend Yield
  • SION N/A
  • LEGH N/A
  • EPS Growth
  • SION N/A
  • LEGH 8.04
  • EPS
  • SION N/A
  • LEGH 2.29
  • Revenue
  • SION N/A
  • LEGH $176,618,000.00
  • Revenue This Year
  • SION N/A
  • LEGH N/A
  • Revenue Next Year
  • SION N/A
  • LEGH $8.23
  • P/E Ratio
  • SION N/A
  • LEGH $10.47
  • Revenue Growth
  • SION N/A
  • LEGH N/A
  • 52 Week Low
  • SION $7.26
  • LEGH $21.58
  • 52 Week High
  • SION $25.19
  • LEGH $29.31
  • Technical
  • Relative Strength Index (RSI)
  • SION N/A
  • LEGH 63.30
  • Support Level
  • SION N/A
  • LEGH $21.91
  • Resistance Level
  • SION N/A
  • LEGH $24.17
  • Average True Range (ATR)
  • SION 0.00
  • LEGH 0.61
  • MACD
  • SION 0.00
  • LEGH 0.27
  • Stochastic Oscillator
  • SION 0.00
  • LEGH 89.96

About SION SIONNA THERAPEUTICS INC

Sionna Therapeutics Inc is a clinical-stage biopharmaceutical company on a mission to revolutionize the current treatment paradigm for cystic fibrosis (CF) patients by developing novel medicines that normalize the function of the cystic fibrosis transmembrane conductance regulator (CFTR) protein to deliver clinically meaningful benefit to CF patients. CF is a progressive and life-threatening genetic disease caused by inherited mutations in the CFTR gene, which heads to insufficient CFTR function. The Company is managed as one operating segment focused on the research and development of cystic fibrosis therapies.

About LEGH Legacy Housing Corporation (TX)

Legacy Housing Corp builds, sell, and finance manufactured homes and tiny houses that are distributed through a network of independent retailers and company-owned stores and also sold directly to manufactured home communities. The company also provides financing options to its customers to facilitate the sale of homes.

Share on Social Networks: